Sonidegib

Sonidegib is a member of the classo of biphenyls that is the amide obtained by formal condensation of the carboxy group of 2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxylic acid with the amino group of 6-(2,6-dimethylmorpholin-4-yl)pyridin-3-amine. Used (as its phosphate salt) for treatment of locally advanced basal cell carcinoma. Among its listed roles, it functions as a antineoplastic agent, a SMO receptor antagonist and a Hedgehog signaling pathway inhibitor. It belongs to the class of morpholines, an aminopyridine, a member of biphenyls, a member of benzamides, an aromatic ether, an organofluorine compound and a tertiary amino compound. It is grouped under the following drug class(es): Antineoplastic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Erismodegib and sonidegibum. Its PubChem CID is 24775005.

CAS No 956697-53-3
Molecular Formula C26H26F3N3O3
Molecular Weight 485.5 g/mol
Synonyms N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide

Frequently Asked Questions